Literature DB >> 25005622

Exploring the modulation of hypoxia-inducible factor (HIF)-1α by volatile anesthetics as a possible mechanism underlying volatile anesthetic-induced CNS injury.

Emma K Giles1, Andrew J Lawrence, Jhodie R Duncan.   

Abstract

This review summarizes recent research on the potential cognitive and behavioural abnormalities induced by exposure to volatile anesthetics and suggests a role of hypoxia-inducible factor (HIF)-1α in mediating these events. Volatile anesthetics are widely utilized in clinical and research settings, yet the long-term safety of exposure to these agents is under debate. Findings from various animal models suggest volatile anesthetics induce widespread apoptosis in the central nervous system (CNS) that correlates with lasting deficits in learning and memory. Longitudinal analysis of clinical data highlight an increased risk of developmental disorders later in life when children are exposed to volatile anesthetics, particularly when exposures occur over multiple sessions. However, the mechanisms underlying these events have yet to be established. Considering the extensive use of volatile anesthetics, it is crucial that these events are better understood. The possible role of HIF-1α in volatile anesthetic-induced CNS abnormalities will be suggested and areas requiring urgent attention will be outlined.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005622     DOI: 10.1007/s11064-014-1379-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  64 in total

1.  Induction of HIF-1alpha in response to hypoxia is instantaneous.

Authors:  U R Jewell; I Kvietikova; A Scheid; C Bauer; R H Wenger; M Gassmann
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

2.  Cancer prognosis: can anesthesia play a role?

Authors:  Zhongcong Xie
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

3.  Cognitive and behavioral outcomes after early exposure to anesthesia and surgery.

Authors:  Randall P Flick; Slavica K Katusic; Robert C Colligan; Robert T Wilder; Robert G Voigt; Michael D Olson; Juraj Sprung; Amy L Weaver; Darrell R Schroeder; David O Warner
Journal:  Pediatrics       Date:  2011-10-03       Impact factor: 7.124

4.  Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.

Authors:  Ansgar M Brambrink; Alex S Evers; Michael S Avidan; Nuri B Farber; Derek J Smith; Xuezhao Zhang; Gregory A Dissen; Catherine E Creeley; John W Olney
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

5.  Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice.

Authors:  George K Istaphanous; Jennifer Howard; Xinyu Nan; Elizabeth A Hughes; John C McCann; John J McAuliffe; Steve C Danzer; Andreas W Loepke
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

Review 6.  The role of p53 in apoptosis.

Authors:  Joana D Amaral; Joana M Xavier; Clifford J Steer; Cecília M Rodrigues
Journal:  Discov Med       Date:  2010-02       Impact factor: 2.970

7.  Hypoxia inducible factor-1α is involved in the neurodegeneration induced by isoflurane in the brain of neonatal rats.

Authors:  Hong Jiang; Yan Huang; Hui Xu; Yu Sun; Ning Han; Qi Fang Li
Journal:  J Neurochem       Date:  2011-12-15       Impact factor: 5.372

8.  Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.

Authors:  Laura L Benzonana; Nicholas J S Perry; Helena R Watts; Bob Yang; Iain A Perry; Charles Coombes; Masao Takata; Daqing Ma
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

9.  The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits.

Authors:  Koichi Nishikawa; Neil L Harrison
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

10.  Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line.

Authors:  Leila R Aminova; Ambreena Siddiq; Rajiv R Ratan
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.